Drug Profile
K 04C - Kowa
Alternative Names: K-04CLatest Information Update: 07 Jun 2016
Price :
$50
*
At a glance
- Originator Kowa
- Class
- Mechanism of Action Inflammation mediator modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 07 Jun 2016 Discontinued - Phase-III for Inflammation in Japan (PO)